Why do some diseases get studied far more than others?

Here is something you can check rather than take on trust: the amount of research done on a disease does not track how much harm that disease causes.

Some conditions affect enormous numbers of people and attract modest attention. Others affect far fewer and attract a great deal. The mismatch is not a conspiracy, and it is not anyone being careless. It comes from a set of forces that are each individually reasonable.

What attention actually follows

Whether the disease kills you. Fatal conditions get more attention than chronic ones that make life worse for decades. That is a defensible instinct. It also means that a disease causing forty years of itching, bad sleep, and missed school can be systematically undercounted, because the thing it damages is not survival.

Whether anyone can see it. Diseases with visible, dramatic presentations attract attention. Diseases people are embarrassed by, or hide, or assume are normal, do not. Plenty of people never mention a condition to a doctor because they have decided it is just how they are.

Whether there is a tractable target. Issue 2 covered druggability. If a disease has no protein anyone knows how to grip, programmes quietly do not start — and no papers get written about targets nobody is pursuing.

Whether somebody already studied it. This one compounds the hardest. Research builds on research. A disease with a large existing literature has tools, datasets, animal models, and funded labs, so the next study is cheaper and more likely to succeed. A neglected disease is expensive to enter precisely because it was neglected. Attention attracts attention.

Who the patients are. Conditions concentrated in poorer countries, or in populations less represented in the research that has already been done, get less of it. This is the one with the least defensible explanation, and it is well documented.

Why this is good news if you are fifteen

Because a mismatch is an opportunity, and it is one you can find without a laboratory.

If attention followed harm perfectly, every worthwhile question would already have a funded team on it, and there would be nothing for a student to do but wait fifteen years. That is not the situation. The gaps are real, they are large, and quite a lot of them are visible in public databases that anyone can open for free.

That is the entire premise of this foundation. We have no laboratory and we do not discover drugs. What we do is check what the public evidence already says, find places where the strongest evidence and the actual activity do not line up, and publish the mismatch so somebody with a laboratory can argue with us.

Our first dossier found exactly that in eczema: the target with the strongest genetic evidence had no drug pointed at it in that disease, and several targets with far weaker evidence had many. You met that target in Issue 1.

That dossier is still under review and we label it that way everywhere it appears. Read it as a claim being checked, not a settled fact. You are allowed to go and disagree with it — the query is published so that you can.

None of that required permission, funding, or equipment. It required knowing where to look and being willing to check.

Try this

Find a mismatch yourself.

1. Open Open Targets: https://platform.opentargets.org
2. Pick any disease that interests you — one that affects someone you know works well.
3. Sort the associated targets by genetic association score.
4. For the top ten, check the Known Drugs section on each.
5. Write down which high-evidence targets have no drugs at all.

That list took you half an hour and cost nothing. It is a genuine, reproducible observation about where research attention is and is not going.

If you do this and find something interesting, we would like to see it. Student work with its method and data attached can be submitted to our Dossier Registry, where it gets a reviewer and a permanent record with your name on it.

One question to take away

You now know five reasons research attention goes where it goes. Only one of them has anything to do with how much a disease hurts people. What would you change first?